Medical and Scientific: Mater research breakthrough in rare blood cancer fight

23 Mar 2021 - Medical and Scientific

A cancer breakthrough developed in Brisbane is expected to give new hope to patients suffering a rare and deadly form of blood cancer that affects the brain and nervous system. The dual precision treatment designed at Brisbane’s Mater Hospital by haematologist Maher Gandhi is expected to revolutionise the care given to those diagnosed with a non-Hodgkin’s lymphoma called Primary Central Nervous System Lymphoma. Professor Gandhi has spent the past five years researching the disease, which affects between 10 and 20 Australians a year. It is the first large-scale study into PCNSL conducted worldwide as part of an Australian-led international consortium that found the genomic make-up of the lymphoma was fundamentally different from any of the 60 other types.

The Australian; 23/03/2021; Page 3​